About STATICH
STATICH is a Scandinavian, investigator-led, randomised, open, blinded end-point (PROBE) clinical trial of antithrombotic treatment for prevention of ischaemic events after intracerebral haemorrhage.
The trial Sponsor is Oslo University Hospital. The Trial Co-ordinating Centre is Oslo University Hospital in collaboration with Akershus University Hospital.
For information about the background and methods, please see the protocol under “Documents”.
Documents
Protocol
Case Report Forms (CRFs)
CRF randomisation STATICH Antiplatelets
CRF randomisation STATICH Anticoagulants
Scan Transfer Form
Unexpected Serious Adverse Events (SAEs)
Patient material
Patient Information and Consent Form Norway
Patient Information and Consent Form Sweden
Patient Information and Consent Form Denmark
Patient card Norway
Patient card Sweden
Patient card Denmark
Patient contact details form
Statistical Analysis Plan
Statistical Analysis Plan 280824
Other resources
STATICH pocket card for investigators
Contact information
STATICH Co-ordinating Centre
Oslo University Hospital, Ullevål
Department of Geriatric Medicine, Building 20, 4th floor
P.O. Box 4950 Nydalen
NO-0424 Oslo
Norway
Tel./fax: +47 22 11 99 11/12
Trial Manager
Helle Eilertsen
helle.eilertsen(a)statich.no
Trial Co-ordinating Investigator
Ole Morten Rønning
o.m.ronning(a)medisin.uio.no
Trial Co-ordinating Investigator
Torgeir Bruun Wyller
t.b.wyller(a)medisin.uio.no
National Co-ordinating Investigator in Sweden
Johanna Pennlert
johanna.pennlert(a)umu.se
Dept. of Public Health and Clinical Medicine
Umeå University Hospital
SE-90185 Umeå
Sweden
National Co-ordinating Investigator in Sweden
Eva-Lotta Glader
eva-lotta.glader(a)umu.se
Dept. of Public Health and Clinical Medicine
Umeå University Hospital
SE-90185 Umeå
Sweden
National Co-ordinating Investigator in Denmark
Christina Kruuse
christina.kruuse(a)regionh.dk
Dept. of Neurology, Stroke Unit N108
Herlev Gentofte Hospital
Herlev Ringvej 75
DK-2730 Herlev
Denmark
